Dr. Zachary Campbell was awarded $1,998,717 from the National Institute of Health (NIH) for his research on Profiling Translation in Nociceptor Plasticity. Dr. Campbell’s team probe the effects of methylglyoxal on translational control and determine if blocking the integrated stress response is a viable option for neuropathic pain. The project involves mechanisms that promote chronic pain to gain a better understanding of disease mechanisms for the eventual development of more effective therapeutics.
Dr. Zachary Campbell Receives $1.9 Million From NIH
by Jasmine Clark